US Patent Issued to PARADIGM BIOPHARMACEUTICALS on April 1 for "Treatment of bone marrow pathologies with polysulfated polysaccharides" (Australian Inventors)

ALEXANDRIA, Va., April 2 -- United States Patent no. 12,263,187, issued on April 1, was assigned to PARADIGM BIOPHARMACEUTICALS LTD (Melbourne, Australia).

"Treatment of bone marrow pathologies with polysulfated polysaccharides" was invented by Ravi Krishnan (Royston Park, Australia) and Paul Rennie (West Beach, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the medical use of polysulfated polysaccharides and compositions thereof for the treatment of disease or disorders associated with bone marrow pathologies in the musculoskeletal system of a mammal. In particular, the invention relates to use of polysulfated polysaccharides, such as pentosan polysulfate, in treat...